Stereotaxis IncSTXS
Price$1.20Intrinsic value$2.1075% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $30.1M+11.7% YoYTTM through 30 Jun 2026
Net Income -$22.3MTTM through 30 Jun 2026
Free Cash Flow -$15.5MTTM through 30 Jun 2026

Margins

Current
Gross Margin60.3%
EBITDA Margin-71.4%
Operating Margin-95.4%
Net Margin-74.2%

Returns

-153.2%ROE
-40.1%ROA

Balance Sheet Health

Debt / Equity0.37x
Current Ratio1.56x
Net Debt-$9.3Mnet cash position
Cash & Equivalents$10.5M

Quality Metrics

Altman Z-Score-13.31
Piotroski F-Score4 / 9
FCF Margin-51.6%
Rule of 40-20.5
Earnings-Beat Rate66.7%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $32.4M
Diluted EPS-$0.24TTM
'19'20'21'22'23'24'25
FY2025: $-0.24

Dividend

No dividend

Capital Allocation

R&D Spend$10M
Capex Intensity0.7%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.